PHILADELPHIA--(BUSINESS WIRE)--PolyMedix, Inc. (OTC BB: PYMX), an emerging biotech company developing acute care products for infectious diseases and acute cardiovascular disorders based on biomimetics, announced that Dr. Gregory Tew and Dr. Byron Brehm-Stecher will be presenting data today at the 234th national annual meeting of the American Chemical Society in Boston relating to PolyMedix’s proprietary antimicrobial compounds.
